4.8 Article

Maternal Vitamin A Supplementation and Lung Function in Offspring

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 362, 期 19, 页码 1784-1794

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa0907441

关键词

-

资金

  1. Bill and Melinda Gates Foundation [614]
  2. Sight and Life Research Institute, Baltimore
  3. Johns Hopkins University [HRN-A-0097-00015-00]
  4. Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development [HRN-A-0097-00015-00]
  5. Task Force Sight and Life, Basel, Switzerland
  6. National Heart, Lung, and Blood Institute, National Institutes of Health [K99HL096955]

向作者/读者索取更多资源

BACKGROUND Vitamin A is important in regulating early lung development and alveolar formation. Maternal vitamin A status may be an important determinant of embryonic alveolar formation, and vitamin A deficiency in a mother during pregnancy could have lasting adverse effects on the lung health of her offspring. We tested this hypothesis by examining the long-term effects of supplementation with vitamin A or beta carotene in women before, during, and after pregnancy on the lung function of their offspring, in a population with chronic vitamin A deficiency. METHODS We examined a cohort of rural Nepali children 9 to 13 years of age whose mothers had participated in a placebo-controlled, double-blind, cluster-randomized trial of vitamin A or beta-carotene supplementation between 1994 and 1997. RESULTS Of 1894 children who were alive at the end of the original trial, 1658 (88%) were eligible to participate in the follow-up trial. We performed spirometry in 1371 of the children (83% of those eligible) between October 2006 and March 2008. Children whose mothers had received vitamin A had a forced expiratory volume in 1 second (FEV1) and a forced vital capacity (FVC) that were significantly higher than those of children whose mothers had received placebo (FEV1, 46 ml higher with vitamin A; 95% confidence interval [CI], 6 to 86; FVC, 46 ml higher with vitamin A; 95% CI, 8 to 84), after adjustment for height, age, sex, body-mass index, calendar month, caste, and individual spirometer used. Children whose mothers had received beta carotene had adjusted FEV1 and FVC values that were similar to those of children whose mothers had received placebo (FEV1, 14 ml higher with beta carotene; 95% CI, -24 to 54; FVC, 17 ml higher with beta carotene, 95% CI, -21 to 55). CONCLUSIONS In a chronically undernourished population, maternal repletion with vitamin A at recommended dietary levels before, during, and after pregnancy improved lung function in offspring. This public health benefit was apparent in the preadolescent years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Critical Care Medicine

Mortality in ETHOS: A Question of Power Reply

David A. Lipson, MeiLan K. Han, Robert Wise, Fernando J. Martinez

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Obstetrics & Gynecology

Reliability of maternal recall of delivery and immediate newborn care indicators in Sarlahi, Nepal

Emily D. Carter, Karen T. Chang, Luke C. Mullany, Subarna K. Khatry, Steven C. LeClerq, Melinda K. Munos, Joanne Katz

Summary: The study assessed the reliability of maternal reports on delivery and immediate newborn care in Sarlahi, Nepal, and found that many interventions were not reliably reported, especially in facility births. This suggests that household surveys relying on maternal reports may not be suitable for collecting data on interventions during the peripartum period.

BMC PREGNANCY AND CHILDBIRTH (2021)

Article Critical Care Medicine

Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health Results of the CLEAN AIR Study

Nadia N. Hansel, Nirupama Putcha, Han Woo, Roger Peng, Gregory B. Diette, Ashraf Fawzy, Robert A. Wise, Karina Romero, Meghan F. Davis, Ana M. Rule, Michelle N. Eakin, Patrick N. Breysse, Meredith C. McCormack, Kirsten Koehler

Summary: This is the first environmental intervention study conducted among former smokers with COPD, showing potential health benefits of portable high-efficiency particulate absolute air cleaners in improving respiratory morbidity.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Review Medicine, General & Internal

The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice

Ian M. Adcock, Surya P. Bhatt, Ronald Balkissoon, Robert A. Wise

Summary: Inhaled corticosteroids (ICS) in combination with bronchodilators are commonly used in primary care settings for patients with chronic obstructive pulmonary disease (COPD). However, ICS-containing therapies may be less effective in COPD patients, especially in those who continue to smoke. Studies have shown that the inflammation in COPD is different from asthma, and exposure to cigarette smoke alters the functioning of glucocorticoid receptors and other anti-inflammatory mechanisms. Therefore, ICS treatment may be relatively ineffective in COPD patients, particularly in smokers. Inappropriate use of ICS therapies in COPD patients can increase the risk of side effects such as pneumonia and bone fractures. Careful evaluation and selection of anti-inflammatory/bronchodilatory strategies based on individual patient characteristics and current guidelines are crucial for the treatment of COPD.

AMERICAN JOURNAL OF MEDICINE (2022)

Article Critical Care Medicine

Home Dust Allergen Exposure Is Associated with Outcomes among Sensitized Individuals with Chronic Obstructive Pulmonary Disease

Nirupama Putcha, Han Woo, Meredith C. McCormack, Ashraf Fawzy, Karina Romero, Meghan F. Davis, Robert A. Wise, Gregory B. Diette, Kirsten Koehler, Elizabeth C. Matsui, Nadia N. Hansel

Summary: This study investigated the sensitivity of COPD patients to common indoor allergens and its association with symptoms and exacerbation risk. The results showed a significant correlation between sensitization and exposure with lower lung function, higher respiratory questionnaire scores, and higher exacerbation risk. Allergens are identified as an important home exposure in COPD, which could potentially be addressed through comprehensive home environmental modification strategies to improve outcomes.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Critical Care Medicine

Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III

Meredith C. McCormack, Aparna Balasubramanian, Elizabeth C. Matsui, Roger D. Peng, Robert A. Wise, Corinne A. Keet

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Cell Biology

Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial

Carolyn M. Boudreau, John S. Burke, Kiel D. Shuey, Caitlin Wolf, Joanne Katz, James Tielsch, Subarna Khatry, Steven C. LeClerq, Janet A. Englund, Helen Y. Chu, Galit Alter

Summary: Seasonal influenza vaccination during pregnancy can provide immunity for infants, and the transfer of selective FCGR-binding antibodies contributes to the protective immune response against influenza in infants.

CELL REPORTS (2022)

Article Critical Care Medicine

Clinical Trial of Losartan for Pulmonary Emphysema Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial

Robert A. Wise, Janet T. Holbrook, Robert H. Brown, Gerard J. Criner, Mark T. Dransfield, Jiaxian He, Robert J. Henderson, David A. Kaminsky, Robert J. Kaner, Stephen C. Lazarus, Barry J. Make, Meredith C. McCormack, Enid R. Neptune, Loretta G. Que

Summary: This study aimed to evaluate the efficacy of losartan in reducing emphysema progression in COPD patients, and the results showed that losartan did not prevent emphysema progression.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Critical Care Medicine

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

Peter M. A. Calverley, Fernando J. Martinez, Jorgen Vestbo, Christine R. Jenkins, Robert Wise, David A. Lipson, Nicholas J. Cowans, Julie Yates, Courtney Crim, Bartolome R. Celli

Summary: Countries participating in COPD trials consistently differ in reporting exacerbations, which may explain why large studies are needed to show differences in exacerbation risk reduction between treatments.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Critical Care Medicine

Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials Reply

Robert A. Wise, Janet T. Holbrook

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Respiratory System

Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

Andrea Gabrio, Necdet B. Gunsoy, Gianluca Baio, Alan Martin, Victoria F. Paly, Nancy Risebrough, David M. G. Halpin, Dave Singh, Robert A. Wise, MeiLan K. Han, Fernando J. Martinez, Gerard J. Criner, Neil Martin, David A. Lipson, Afisi S. Ismaila

Summary: Triple therapy with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) showed better clinical benefits compared to dual therapy in the treatment of COPD, and also resulted in lower healthcare resource utilization costs related to COPD.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2022)

Article Allergy

Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence

Joan Reibman, Bradley E. Chipps, Robert S. Zeiger, David A. Beuther, Robert A. Wise, William McCann, Ileen Gilbert, James M. Eudicone, Hitesh N. Gandhi, Gale Harding, Katelyn Cutts, Karin S. Coyne, Kevin R. Murphy, Maureen George

Summary: Purpose of this study was to assess the construct validity of the Asthma Impairment and Risk Questionnaire (AIRQ) by comparing it with patient self-perception of asthma status and validated disease-specific patient-reported outcome measures. The results showed significant correlations between AIRQ score and patient self-perception, as well as scores from other validated measures. As the AIRQ control category worsened, scores from other measures also worsened. This study demonstrates that AIRQ can be a useful instrument to raise awareness of the impacts of asthma on patients' lives.

JOURNAL OF ASTHMA AND ALLERGY (2023)

Article Allergy

Subgroup Analysis of a Randomized Trial of the Effects of Positive Messaging on Patient-Reported Outcomes with Asthma-Effect of Obesity

Anne M. Mathews, Isaretta Riley, Robert Henderson, Janet T. Holbrook, Jason E. Lang, Anne E. Dixon, Robert A. Wise, Loretta G. Que

Summary: Obesity is an important factor associated with asthma outcomes and may modify the effects of drug treatment. This study aimed to evaluate obesity as a potential treatment effect modifier of enhanced drug messaging or placebos on subjective asthma outcomes.

JOURNAL OF ASTHMA AND ALLERGY (2022)

Article Cardiac & Cardiovascular Systems

Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma

David A. Kaminsky, Jiaxian He, Robert Henderson, Anne E. Dixon, Charles G. Irvin, John Mastronarde, Lewis J. Smith, Elizabeth A. Sugar, Robert A. Wise, Janet T. Holbrook

Summary: The purpose of this study was to determine the relationship between four different definitions of bronchodilator response (BDR) and asthma control and symptom burden in participants with poorly controlled asthma. The study found that there was no association between BDR and asthma control or symptoms, regardless of the definition used. These findings question the clinical utility of BDR in assessing asthma control and symptoms.

RESPIRATORY MEDICINE (2023)

Article Respiratory System

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT

Nirupama Putcha, Antonio R. Anzueto, Peter M. A. Calverley, Bartolome R. Celli, Donald P. Tashkin, Norbert Metzdorf, Achim Mueller, Robert A. Wise

Summary: There is an association between body mass index (BMI) and adverse outcomes in COPD, with underweight individuals having higher mortality and exacerbation risk. Overweight and obese individuals are at lower risk or no additional risk. A holistic management approach is needed to improve the general well-being of COPD patients.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)

暂无数据